-
Mashup Score: 60
Media Advisory Nov. 1, 2021 Contact information Today’s update includes 2,857 newly reported cases and 7,597 reinfection cases recorded since the start of the pandemic for a total of 10,454 As part of the data updates announced last Wednesday, the Minnesota Department of Health (MDH) today is adding the number of COVID-19 reinfections to the total shown under the Minnesota…
Source: www.health.state.mn.usCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice - 2 year(s) ago
The monoclonal antibody, DH1047, broadly protects in vivo against pre-emergent bat SARS-related viruses, SARS-CoV, and SARS-CoV-2 variants.
Source: Science Translational MedicineCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
mRNA vaccines that express chimeric spike protein protect mice against epidemic, zoonotic, and pandemic SARS-like viruses.
Source: ScienceCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: HIV/AIDS, Latest HeadlinesTweet-
Directly from the editor on @MattSpinelliMD's work: This well conducted study helps clarify the risk for more severe #COVID among #PWH. Srsly, read on: https://t.co/3DUgfzaoLQ
-
-
Mashup Score: 12
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other coronaviruses rely on a cohort of specialized viral proteins to transcribe and replicate their RNA genomes. Recent studies have improved our understanding of coronavirus RNA translation, replication and transcription, and offer new therapeutic targets.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 14
SARS-CoV-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. We present a case of an immunocompromised patient with acquired B-cell deficiency who developed an indolent, protracted course of SARS-CoV-2 infection. Remdesivir therapy alleviated symptoms and produced a transient virologic response, but…
Source: medRxivCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 9Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs - 3 year(s) ago
Durable protection against COVID-19 infection may be achieved by generating robust T cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and emerging SARS-CoV-2 variants; for those infected, effective treatments are urgently needed. For these strategies to be successful, accurate identification of T cell epitopes is critical. In this study, we used major…
Source: PNASCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 4
Research Letter Open Access Published: 19 August 2021 Critical…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 1Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort - Critical Care - 3 year(s) ago
Background Intensive Care Resources are heavily utilized during the COVID-19 pandemic. However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon ICU admission remain inadequate. This study aimed to develop a machine learning model, based on retrospective & prospective clinical data, to stratify patient risk and predict ICU survival and outcomes. Methods A…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 17South Africa’s potential new variant - 3 year(s) ago
The most highly mutated Covid-19 variant yet is now circulating in most of the country.
Source: New FrameCategories: Hematologists1, Latest HeadlinesTweet
RT @AliNouriPhD: 📌Minnesota is now counting reinfections: ~8,000 #SARS_CoV_2 reinfections since start of pandemic: https://t.co/cvJLlPYeIw…